|
MAGI1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65800706497521E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.74604775082798E-12 |
| Normal-vs-Stage2 |
5.44029998827966E-09 |
| Normal-vs-Stage3 |
1.62625468647093E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
1.264550E-01 |
| Stage1-vs-Stage3 |
5.364200E-02 |
| Stage1-vs-Stage4 |
5.790500E-04 |
| Stage2-vs-Stage3 |
8.175500E-03 |
| Stage2-vs-Stage4 |
7.789000E-04 |
| Stage3-vs-Stage4 |
1.588790E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60982338570648E-14 |
| Normal-vs-AfricanAmerican |
1.0766000000384E-06 |
| Normal-vs-Asian |
2.1316282072803E-14 |
| Caucasian-vs-AfricanAmerican |
1.363370E-01 |
| Caucasian-vs-Asian |
6.172200E-01 |
| AfricanAmerican-vs-Asian |
1.368590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66833213910422E-12 |
| Normal-vs-Female |
1.66144875635155E-12 |
| Male-vs-Female |
9.210000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.58442181386454E-14 |
| Normal-vs-Age(41-60Yrs) |
4.03010957938932E-14 |
| Normal-vs-Age(61-80Yrs) |
1.67921232474555E-12 |
| Normal-vs-Age(81-100Yrs) |
6.21659999999746E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.375400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.885600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.871800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.360400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.801600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.751200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.60630439242027E-11 |
| Classical-VS-Follicular |
3.358800E-03 |
| Classical-VS-Other |
4.485200E-01 |
| Classical-VS-Normal |
1.65645275274073E-13 |
| Tall-VS-Follicular |
6.60038690369902E-12 |
| Tall-VS-Other |
2.148300E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.326260E-02 |
| Follicular-VS-Normal |
1.00999997254547E-09 |
| Other-VS-Normal |
2.71080002889335E-09 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.91575660785293E-13 |
| Normal-vs-N1 |
3.66373598126302E-15 |
| N0-vs-N1 |
2.933700E-02 |
|
|
